| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6061263 | Sleep Medicine | 2012 | 4 Pages |
Abstract
FCM led to a considerable improvement in RLS in the responder group within about one week. These findings are clinically relevant, especially for patients with severe RLS symptoms and iron deficiency, since a change or uptitration of RLS-specific medication can be avoided or postponed in these patients due to the rapid response to IV FCM treatment.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Magdolna Hornyak, Hanna Scholz, Andrea Kiemen, Jan Kassubek,